INTEGUMENT-OLE and What’s Next for Pediatric AD: Pediatric dermatologist Larry Eichenfield, MD, talks about the INTEGUMENT-OLE study data and the impact of the roflumilast cream 0.05% (Zoryve) on the treatment of mild-to-moderate atopic dermatitis in children aged 2 to 5 years.
Watch here ➡️ https://t.co/RqdrhZcDMP
📢🚨PRACTICAL DERMATOLOGY MAY/JUNE ISSUE: The May/June 2026 issue of @PracticalDerm explores modern approaches to treating skin cancers—from gene expression profiling and immunotherapy to intralesional therapies and prevention. Read the full issue ➡️ https://t.co/ShGidYB6MZ #Dermatology #SkinCancer #CutaneousOncology #MedicalDermatology
🧵 New in @JAMADerm:Neoadjuvant #capecitabine showed promising activity in advanced cutaneous SCC of the head & neck. Potential bridge for patients awaiting surgery or unable to receive immunotherapy? Read more ➡️ https://t.co/CgwmMV9Yq8
#cSCC#Dermatology#SkinCancer
📢JUNE IS ACNE AWARENESS MONTH 🩺👉Acne is one of the most common dermatologic conditions worldwide—but its impact extends beyond the skin. This #AcneAwarenessMonth, we're highlighting the latest treatment advances, clinical research, and expert insights. Learn more at https://t.co/ae8OAtwzIJ. #AcneAwarenessMonth #Dermatology #ClinicalResearch #HealthcareInnovation #MedicalEducation #SkinHealth
🎙️ 👨⚕️👨⚕️ SCIENCE OF SKIN PODCAST TALKS HIDRADENITIS SUPPURATIVA: In this episode of The Science of Skin Podcast, Practical Dermatology Editorial Board member and Science of Skin Summit Co-founder Edward (Ted) Lain, MD, MBA, is joined by Steven Daveluy, MD, FAAD, to discuss the complicated pathophysiology of hidradenitis suppurativa and the future of treatment capabilities for the disease ➡️ https://t.co/Ok9clxAbLS #HidradenitisSuppurativa #SkinScience #SkinHealth #PracticalDermatologyPodcast #Dermatology #HSAwareness
📊🎤🩺GOING IN-DEPTH FOR PIGMENTARY DISORDERS: Pearl E. Grimes, MD, FAAD, previews the Pigmentary Disorders Exchange Symposium, which will be held June 6-7 at the Loews Chicago Hotel ➡️ https://t.co/VwYQEDfjBo
One registration. Two industry-leading experiences. Unlimited opportunity to be part of the conversations shaping the future of aesthetic regenerative medicine.
Genesis and the Tell-All Tribune bring together groundbreaking science, honest discussion, emerging trends, and real-world clinical application led by top physicians, scientists, and innovators.
If you want more than surface-level education, this is where you need to be.
Register early to secure the best rates before pricing increases!
📍 Miami, FL | August 21–22, 2026
🔗 https://t.co/dIuidqvbB4
🧴📊🩺THE ROLE OF BPO IN LONG-TERM ACNE MANAGEMENT: In a recent virtual deskside given by Revance, speakers emphasized the importance of early #acne intervention to help reduce the risk of long-term physical and emotional scarring. Dermatologist Suneel Chilukuri, MD, participated in the discussion and highlighted growing consumer engagement with the #PanOxyl portfolio ➡️ https://t.co/2jDbM4TWFn #dermatology #acnemanagement #BPO #skinhealth #Skincare
🔎 ULTRASOUND FOR #PSORIASIS: New research suggests musculoskeletal ultrasound may detect subclinical inflammation in children with psoriasis before arthritis symptoms emerge. Pediatric patients showed more frequent synovitis and abnormal nail findings versus healthy controls📊 ➡️ https://t.co/0X7RwOMAT8 #DermTwitter #Rheumatology #PediatricDermatology #Ultrasound
📢📊👉NEW DATA: Could botulinum toxin A have a larger role in acne management? A new systematic review of 436 patients found improvements in acne lesions, sebum production, and acne scarring outcomes lasting 3-6 months ➡️ https://t.co/E4zPMw0UDW #DermTwitter#Acne#Aesthetics
📰 👈NEWS: Ixekizumab + tirzepatide improved both PASI 100 and ≥10% weight loss in adults with psoriasis and obesity in a phase 3b trial published in JAMA Dermatology. Combination therapy achieved the primary endpoint in 27.1% vs 5.8% with ixekizumab alone.
Read more ➡️ https://t.co/5egBGm7gvj
#psoriasis #dermatology
👉NEW: A study in JAMA Dermatology shows adolescent isotretinoin use was not associated with reduced adult height in a nationwide Danish cohort of nearly 380K individuals. Findings were consistent across age and dose analyses ➡️ https://t.co/YnQQDIuGMH
#Dermatology#Acne #Isotretinoin #JAMADermatology
💉 GLP-1 therapies are reshaping aesthetic dermatology. At #MusicCitySCALE2026, Terrence Keaney, MD, discussed how rapid weight loss can contribute to:
✨ Facial volume loss
✨ Skin laxity
✨ Hair shedding
✨ Muscle loss
📖 Read more ➡️ https://t.co/jVLTnXCCSz #Dermatology #AestheticMedicine #GLP1 #OzempicFace #SkinLaxity #HairLoss #DermatologyNews
🚨🌍📈 NEW: Global burden of melanoma, cSCC, and BCC projected to rise sharply through 2050, especially in low- and middle-SDI regions. Melanoma DALYs may exceed 3.3 million globally by 2050 ➡️ https://t.co/G4PlgOQPG1 #SkinCancer#Dermatology#Melanoma#BCC#cSCC#DermNews #DermatologyResearch #Oncology #PublicHealth
🩺 🎤🎶 SCALE 2026 IS HERE: Practical Dermatology is on scene at Music City SCALE in Nashville, covering the latest trends, expert analysis, and clinical innovations shaping aesthetic and laser medicine. Follow along for meeting highlights and key takeaways from the field. #MusicCitySCALE #Dermatology
📱TEXTME PSO: A randomized trial in JAMA Dermatology found text-message support improved patient activation, diet adherence, medication adherence, and physical activity in psoriasis patients🔎📊 ➡️ https://t.co/RM9eA4glAb
#Psoriasis#Dermatology#DigitalHealth#SkinHealth #CardiovascularHealth